EpCAM overexpression was not associated with age, pT stage, lymph node metastasis, number of lymph node, prostate-specific antigen (PSA) level, biochemical recurrence, and overall survival. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.